Eli Lilly & Co. (LLY)
1009.52
-13.70
(-1.34%)
USD |
NYSE |
Feb 20, 16:00
1011.60
+2.08
(+0.21%)
Pre-Market: 20:00
Eli Lilly Shareholders Equity (Quarterly) : 26.54B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Biogen, Inc. | 18.26B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Viking Therapeutics, Inc. | 639.06M |
| Moderna, Inc. | 8.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.48B |
| Total Liabilities (Quarterly) | 85.94B |
| Debt to Equity Ratio | 1.653 |
| Current Ratio | 1.579 |
| Net Debt Paydown Yield | -0.27% |